Global Rapid Acting Insulins Market Growth (Status and Outlook) 2022-2028

January 2021 | 60 pages | ID: GFC6E4E2A97EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

As the global economy mends, the 2021 growth of Rapid Acting Insulins will have significant change from previous year. According to our (LP Information) latest study, the global Rapid Acting Insulins market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Rapid Acting Insulins market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Rapid Acting Insulins market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Rapid Acting Insulins market, reaching US$ million by the year 2028. As for the Europe Rapid Acting Insulins landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Rapid Acting Insulins players cover Eli Lilly, Novo Nordisk, Sanofi, and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Rapid Acting Insulins market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

• Lispro
• Aspart (NovoLog)
• Glulisine (Apidra)

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

• Type 1 Diabetes
• Type 2 Diabetes

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

• Eli Lilly
• Novo Nordisk
• Sanofi

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Rapid Acting Insulins Market Size 2017-2028
  2.1.2 Rapid Acting Insulins Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Rapid Acting Insulins Segment by Type
  2.2.1 Lispro
  2.2.2 Aspart (NovoLog)
  2.2.3 Glulisine (Apidra)
2.3 Rapid Acting Insulins Market Size by Type
  2.3.1 Rapid Acting Insulins Market Size CAGR by Type (2017 VS 2022 VS 2028)
  2.3.2 Global Rapid Acting Insulins Market Size Market Share by Type (2017-2022)
2.4 Rapid Acting Insulins Segment by Application
  2.4.1 Type 1 Diabetes
  2.4.2 Type 2 Diabetes
2.5 Rapid Acting Insulins Market Size by Application
  2.5.1 Rapid Acting Insulins Market Size CAGR by Application (2017 VS 2022 VS 2028)
  2.5.2 Global Rapid Acting Insulins Market Size Market Share by Application (2017-2022)

3 RAPID ACTING INSULINS MARKET SIZE BY PLAYER

3.1 Rapid Acting Insulins Market Size Market Share by Players
  3.1.1 Global Rapid Acting Insulins Revenue by Players (2020-2022)
  3.1.2 Global Rapid Acting Insulins Revenue Market Share by Players (2020-2022)
3.2 Global Rapid Acting Insulins Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 RAPID ACTING INSULINS BY REGIONS

4.1 Rapid Acting Insulins Market Size by Regions (2017-2022)
4.2 Americas Rapid Acting Insulins Market Size Growth (2017-2022)
4.3 APAC Rapid Acting Insulins Market Size Growth (2017-2022)
4.4 Europe Rapid Acting Insulins Market Size Growth (2017-2022)
4.5 Middle East & Africa Rapid Acting Insulins Market Size Growth (2017-2022)

5 AMERICAS

5.1 Americas Rapid Acting Insulins Market Size by Country (2017-2022)
5.2 Americas Rapid Acting Insulins Market Size by Type (2017-2022)
5.3 Americas Rapid Acting Insulins Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Rapid Acting Insulins Market Size by Region (2017-2022)
6.2 APAC Rapid Acting Insulins Market Size by Type (2017-2022)
6.3 APAC Rapid Acting Insulins Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Rapid Acting Insulins by Country (2017-2022)
7.2 Europe Rapid Acting Insulins Market Size by Type (2017-2022)
7.3 Europe Rapid Acting Insulins Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Rapid Acting Insulins by Region (2017-2022)
8.2 Middle East & Africa Rapid Acting Insulins Market Size by Type (2017-2022)
8.3 Middle East & Africa Rapid Acting Insulins Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL RAPID ACTING INSULINS MARKET FORECAST

10.1 Global Rapid Acting Insulins Forecast by Regions (2023-2028)
  10.1.1 Global Rapid Acting Insulins Forecast by Regions (2023-2028)
  10.1.2 Americas Rapid Acting Insulins Forecast
  10.1.3 APAC Rapid Acting Insulins Forecast
  10.1.4 Europe Rapid Acting Insulins Forecast
  10.1.5 Middle East & Africa Rapid Acting Insulins Forecast
10.2 Americas Rapid Acting Insulins Forecast by Country (2023-2028)
  10.2.1 United States Rapid Acting Insulins Market Forecast
  10.2.2 Canada Rapid Acting Insulins Market Forecast
  10.2.3 Mexico Rapid Acting Insulins Market Forecast
  10.2.4 Brazil Rapid Acting Insulins Market Forecast
10.3 APAC Rapid Acting Insulins Forecast by Region (2023-2028)
  10.3.1 China Rapid Acting Insulins Market Forecast
  10.3.2 Japan Rapid Acting Insulins Market Forecast
  10.3.3 Korea Rapid Acting Insulins Market Forecast
  10.3.4 Southeast Asia Rapid Acting Insulins Market Forecast
  10.3.5 India Rapid Acting Insulins Market Forecast
  10.3.6 Australia Rapid Acting Insulins Market Forecast
10.4 Europe Rapid Acting Insulins Forecast by Country (2023-2028)
  10.4.1 Germany Rapid Acting Insulins Market Forecast
  10.4.2 France Rapid Acting Insulins Market Forecast
  10.4.3 UK Rapid Acting Insulins Market Forecast
  10.4.4 Italy Rapid Acting Insulins Market Forecast
  10.4.5 Russia Rapid Acting Insulins Market Forecast
10.5 Middle East & Africa Rapid Acting Insulins Forecast by Region (2023-2028)
  10.5.1 Egypt Rapid Acting Insulins Market Forecast
  10.5.2 South Africa Rapid Acting Insulins Market Forecast
  10.5.3 Israel Rapid Acting Insulins Market Forecast
  10.5.4 Turkey Rapid Acting Insulins Market Forecast
  10.5.5 GCC Countries Rapid Acting Insulins Market Forecast
10.6 Global Rapid Acting Insulins Forecast by Type (2023-2028)
10.7 Global Rapid Acting Insulins Forecast by Application (2023-2028)

11 KEY PLAYERS ANALYSIS

11.1 Eli Lilly
  11.1.1 Eli Lilly Company Information
  11.1.2 Eli Lilly Rapid Acting Insulins Product Offered
  11.1.3 Eli Lilly Rapid Acting Insulins Revenue, Gross Margin and Market Share (2020-2022)
  11.1.4 Eli Lilly Main Business Overview
  11.1.5 Eli Lilly Latest Developments
11.2 Novo Nordisk
  11.2.1 Novo Nordisk Company Information
  11.2.2 Novo Nordisk Rapid Acting Insulins Product Offered
  11.2.3 Novo Nordisk Rapid Acting Insulins Revenue, Gross Margin and Market Share (2020-2022)
  11.2.4 Novo Nordisk Main Business Overview
  11.2.5 Novo Nordisk Latest Developments
11.3 Sanofi
  11.3.1 Sanofi Company Information
  11.3.2 Sanofi Rapid Acting Insulins Product Offered
  11.3.3 Sanofi Rapid Acting Insulins Revenue, Gross Margin and Market Share (2020-2022)
  11.3.4 Sanofi Main Business Overview
  11.3.5 Sanofi Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Rapid Acting Insulins Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Lispro
Table 3. Major Players of Aspart (NovoLog)
Table 4. Major Players of Glulisine (Apidra)
Table 5. Rapid Acting Insulins Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Rapid Acting Insulins Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Rapid Acting Insulins Market Size Market Share by Type (2017-2022)
Table 8. Rapid Acting Insulins Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Rapid Acting Insulins Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Rapid Acting Insulins Market Size Market Share by Application (2017-2022)
Table 11. Global Rapid Acting Insulins Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Rapid Acting Insulins Revenue Market Share by Player (2020-2022)
Table 13. Rapid Acting Insulins Key Players Head office and Products Offered
Table 14. Rapid Acting Insulins Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Rapid Acting Insulins Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Rapid Acting Insulins Market Size Market Share by Regions (2017-2022)
Table 19. Americas Rapid Acting Insulins Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Rapid Acting Insulins Market Size Market Share by Country (2017-2022)
Table 21. Americas Rapid Acting Insulins Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Rapid Acting Insulins Market Size Market Share by Type (2017-2022)
Table 23. Americas Rapid Acting Insulins Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Rapid Acting Insulins Market Size Market Share by Application (2017-2022)
Table 25. APAC Rapid Acting Insulins Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Rapid Acting Insulins Market Size Market Share by Region (2017-2022)
Table 27. APAC Rapid Acting Insulins Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Rapid Acting Insulins Market Size Market Share by Type (2017-2022)
Table 29. APAC Rapid Acting Insulins Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Rapid Acting Insulins Market Size Market Share by Application (2017-2022)
Table 31. Europe Rapid Acting Insulins Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Rapid Acting Insulins Market Size Market Share by Country (2017-2022)
Table 33. Europe Rapid Acting Insulins Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Rapid Acting Insulins Market Size Market Share by Type (2017-2022)
Table 35. Europe Rapid Acting Insulins Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Rapid Acting Insulins Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Rapid Acting Insulins Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Rapid Acting Insulins Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Rapid Acting Insulins Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Rapid Acting Insulins Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Rapid Acting Insulins Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Rapid Acting Insulins Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Rapid Acting Insulins
Table 44. Key Market Challenges & Risks of Rapid Acting Insulins
Table 45. Key Industry Trends of Rapid Acting Insulins
Table 46. Global Rapid Acting Insulins Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Rapid Acting Insulins Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Rapid Acting Insulins Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Rapid Acting Insulins Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Rapid Acting Insulins Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Rapid Acting Insulins Market Size Market Share Forecast by Application (2023-2028)
Table 52. Eli Lilly Details, Company Type, Rapid Acting Insulins Area Served and Its Competitors
Table 53. Eli Lilly Rapid Acting Insulins Product Offered
Table 54. Eli Lilly Rapid Acting Insulins Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Eli Lilly Main Business
Table 56. Eli Lilly Latest Developments
Table 57. Novo Nordisk Details, Company Type, Rapid Acting Insulins Area Served and Its Competitors
Table 58. Novo Nordisk Rapid Acting Insulins Product Offered
Table 59. Novo Nordisk Main Business
Table 60. Novo Nordisk Rapid Acting Insulins Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Novo Nordisk Latest Developments
Table 62. Sanofi Details, Company Type, Rapid Acting Insulins Area Served and Its Competitors
Table 63. Sanofi Rapid Acting Insulins Product Offered
Table 64. Sanofi Main Business
Table 65. Sanofi Rapid Acting Insulins Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Sanofi Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Rapid Acting Insulins Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Rapid Acting Insulins Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Rapid Acting Insulins Market Size Market Share by Type in 2021
Figure 7. Rapid Acting Insulins in Type 1 Diabetes
Figure 8. Global Rapid Acting Insulins Market: Type 1 Diabetes (2017-2022) & ($ Millions)
Figure 9. Rapid Acting Insulins in Type 2 Diabetes
Figure 10. Global Rapid Acting Insulins Market: Type 2 Diabetes (2017-2022) & ($ Millions)
Figure 11. Global Rapid Acting Insulins Market Size Market Share by Application in 2021
Figure 12. Global Rapid Acting Insulins Revenue Market Share by Player in 2021
Figure 13. Global Rapid Acting Insulins Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Rapid Acting Insulins Market Size 2017-2022 ($ Millions)
Figure 15. APAC Rapid Acting Insulins Market Size 2017-2022 ($ Millions)
Figure 16. Europe Rapid Acting Insulins Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Rapid Acting Insulins Market Size 2017-2022 ($ Millions)
Figure 18. Americas Rapid Acting Insulins Value Market Share by Country in 2021
Figure 19. Americas Rapid Acting Insulins Consumption Market Share by Type in 2021
Figure 20. Americas Rapid Acting Insulins Market Size Market Share by Application in 2021
Figure 21. United States Rapid Acting Insulins Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Rapid Acting Insulins Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Rapid Acting Insulins Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Rapid Acting Insulins Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Rapid Acting Insulins Market Size Market Share by Region in 2021
Figure 26. APAC Rapid Acting Insulins Market Size Market Share by Application in 2021
Figure 27. China Rapid Acting Insulins Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Rapid Acting Insulins Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Rapid Acting Insulins Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Rapid Acting Insulins Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Rapid Acting Insulins Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Rapid Acting Insulins Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Rapid Acting Insulins Market Size Market Share by Country in 2021
Figure 34. Europe Rapid Acting Insulins Market Size Market Share by Type in 2021
Figure 35. Europe Rapid Acting Insulins Market Size Market Share by Application in 2021
Figure 36. Germany Rapid Acting Insulins Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Rapid Acting Insulins Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Rapid Acting Insulins Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Rapid Acting Insulins Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Rapid Acting Insulins Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Rapid Acting Insulins Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Rapid Acting Insulins Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Rapid Acting Insulins Market Size Market Share by Application in 2021
Figure 44. Egypt Rapid Acting Insulins Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Rapid Acting Insulins Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Rapid Acting Insulins Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Rapid Acting Insulins Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Rapid Acting Insulins Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Rapid Acting Insulins Market Size 2023-2028 ($ Millions)
Figure 50. APAC Rapid Acting Insulins Market Size 2023-2028 ($ Millions)
Figure 51. Europe Rapid Acting Insulins Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Rapid Acting Insulins Market Size 2023-2028 ($ Millions)
Figure 53. United States Rapid Acting Insulins Market Size 2023-2028 ($ Millions)
Figure 54. Canada Rapid Acting Insulins Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Rapid Acting Insulins Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Rapid Acting Insulins Market Size 2023-2028 ($ Millions)
Figure 57. China Rapid Acting Insulins Market Size 2023-2028 ($ Millions)
Figure 58. Japan Rapid Acting Insulins Market Size 2023-2028 ($ Millions)
Figure 59. Korea Rapid Acting Insulins Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Rapid Acting Insulins Market Size 2023-2028 ($ Millions)
Figure 61. India Rapid Acting Insulins Market Size 2023-2028 ($ Millions)
Figure 62. Australia Rapid Acting Insulins Market Size 2023-2028 ($ Millions)
Figure 63. Germany Rapid Acting Insulins Market Size 2023-2028 ($ Millions)
Figure 64. France Rapid Acting Insulins Market Size 2023-2028 ($ Millions)
Figure 65. UK Rapid Acting Insulins Market Size 2023-2028 ($ Millions)
Figure 66. Italy Rapid Acting Insulins Market Size 2023-2028 ($ Millions)
Figure 67. Russia Rapid Acting Insulins Market Size 2023-2028 ($ Millions)
Figure 68. Spain Rapid Acting Insulins Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Rapid Acting Insulins Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Rapid Acting Insulins Market Size 2023-2028 ($ Millions)
Figure 71. Israel Rapid Acting Insulins Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Rapid Acting Insulins Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Rapid Acting Insulins Market Size 2023-2028 ($ Millions)